SEARCH

SEARCH BY CITATION

To the Editors:

We read with great interest the recent article published in Arthritis Care & Research by Sheane et al about the role of ultrasonography (US) in the evaluation of the fifth metatarsophalangeal (MTP) joint in patients with early arthritis (EA) (1). In the assessment of patients with EA, it is very important to distinguish between different forms of arthritides, such as rheumatoid arthritis (RA) and undifferentiated arthritis (UA), as early as possible after symptom development (2). Recently, US has been indicated as being more sensitive than clinical examination and conventional radiography in the detection of joint erosive damage, and it is frequently applied in the assessment of patients affected by EA (3). Sheane et al, who evaluated 30 patients with a new diagnosis of inflammatory arthritis, indicated that US examination of the fifth MTP joint aids in the identification of early erosive disease and consequent diagnosis of RA. Erosions, synovial hypertrophy, and power Doppler (PD) signal were evaluated, detecting the evidence of fifth MTP joint erosions in more than 50% of patients, which was significantly higher in those with a diagnosis of early RA compared with UA. Significant differences between radiographic- and US-detected erosions in the fifth MTP joint were evident, with correlation between US-detected synovial hypertrophy and radiographic erosions. We would like to address the following comments.

First, Sheane and colleagues seem to consider the presence of synovial hypertrophy as indicative of synovitis and use those 2 terms as being synonymous. We wonder if this is correct, considering that Outcome Measures in Rheumatology Clinical Trials (OMERACT) definitions refer to synovial hypertrophy and synovial fluid and do not mention the term “synovitis.” Second, we believe that the use of warm water bath could influence the appearance of PD signal, due to vasodilatation correlated to increase of local temperature. The use of US gel and the avoidance of probe pressure over the area of interest are commonly considered as reliable procedures for correct sonographic scanning of musculoskeletal structures and usually ensure a good image quality (4). Furthermore, after reading this interesting study by Sheane et al, we would like to report our experience with 49 consecutive patients with EA who were referred to the EA clinic of the rheumatology unit at Sapienza University of Rome. In our cohort, we examined MTP joints both by grey scale and PD US by using a Philips/HP Image Point HX machine (Philips, Amsterdam, The Netherlands) equipped with a 14 MHz linear probe and PD (setting: frequency 7 MHz, pulse repetition frequency 700–1,000, gain 18–30 dB, low filter). US gel was used. According to OMERACT definitions, we evaluated synovial fluid, synovial proliferation, PD, and erosions (5). All findings were scored by using a dichotomous assessment (0 = absent, 1 = present). US findings in MTP joints of patients with EA, subgrouped according to a diagnosis of either RA or UA, are reported in Tables 1 and 2, where US modifications referred only to the fifth MTP joint and all MTP joints are described.

Table 1. US findings in 49 patients with early RA and UA*
 RA patients (n = 25)UA patients (n = 24)Total patients (n = 49)P
  • *

    Values are the number (percentage) unless otherwise indicated. All comparisons of frequency between the groups were made using Fisher's exact test. All P values were 2-tailed, and the significance cutoff was P < 0.05. US = ultrasonography; RA = rheumatoid arthritis; UA = undifferentiated arthritis; MTP = metatarsophalangeal; NS = not significant; PD = power Doppler.

US erosions fifth MTP joint3 (12)1 (4)4 (8.1)NS
US synovial proliferation fifth MTP joint3 (12)2 (8.3)5 (10.2)NS
US synovial effusion fifth MTP joint6 (25)3 (12.5)9 (18.3)NS
PD-positive fifth MTP joint2 (8)1 (4)3 (6)NS
Table 2. US findings in 490 joints (first to fifth MTP) in patients with early RA and UA*
 RA MTP joints (n = 250)UA MTP joints (n = 240)Total joints (n = 490)P
  • *

    Values are the number (percentage) unless otherwise indicated. All comparisons of frequency between the groups were made using Fisher's exact test. All P values were 2-tailed, and the significance cutoff was P < 0.05. US = ultrasonography; MTP = metatarsophalangeal; RA = rheumatoid arthritis; UA = undifferentiated arthritis; PD = power Doppler; NS = not significant.

US erosions MTP joints32 (12.8)14 (5.8)46 (9.3)0.008
US synovial proliferation MTP joints53 (21.2)11 (4.6)64 (13.1)< 0.001
US synovial effusion MTP joints66 (26.4)36 (15)102 (20.1)0.002
PD-positive MTP joints10 (4)8 (3.3)18 (3.7)NS

In our cohort, US evaluation of the fifth MTP joint showed a lower percentage of patients with bony erosions compared with the study by Sheane et al (8.1% versus 56.7%), confirming a higher prevalence in RA patients with respect to UA (12% versus 4%). Moreover, we did not find significant differences between the 2 groups of patients concerning the presence of PD signal. The extension of US evaluation to bilateral first to fifth MTP joints in all 49 patients confirmed a similar prevalence of erosions detected by US (9.3% versus 8.1%). By a different point of view, based on the analysis of MTP joint involvement, we demonstrated significant differences between RA and UA concerning the percentage of joints with erosions, synovial effusion, and proliferation (P = 0.008, P < 0.001, and P = 0.002, respectively).

In conclusion, according to our experience, we agree with Sheane and colleagues on the relevant role of US of the fifth MTP joint in the assessment of patients with EA. Considering, however, that all MTP joints were more frequently and earlier involved in RA than in UA, we propose the extension of US evaluation to all of the MTP joints and not only to the fifth. In our opinion, this procedure would not significantly increase the time duration of a single US examination session and would improve the entity of information obtained, thereby helping to differentiate between early RA and UA. Further studies on larger cohorts and longitudinal research studies are needed to confirm these results.

  • 1
    Sheane BJ, Beddy P, O'Connor M, Miller S, Cunnane G. Targeted ultrasound of the fifth metatarsophalangeal joint in an early inflammatory arthritis cohort. Arthritis Rheum 2009; 61: 10048.
  • 2
    Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 35765.
  • 3
    Szkudlarek M, Narvestad E, Klarlund M, Court-Payen M, Thomsen HS, Ostergaard M. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 2004; 50: 210312.
  • 4
    Iagnocco A, Epis O, Delle Sedie A, Meenagh G, Filippucci E, Riente L, et al. Ultrasound imaging for the rheumatologist. XVII. Role of colour Doppler and power Doppler. Clin Exp Rheumatol 2008; 26: 75962.
  • 5
    Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, et al. OMERACT 7 Special Interest Group: musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32: 24857.

Fulvia Ceccarelli MD*, Annamaria Iagnocco MD*, Manuela Di Franco MD*, Cristina Iannuccelli MD*, Guido Valesini MD*, * Sapienza University of Rome, Rome, Italy.